Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-29

Clinical Trial Update: Clinical Study of the Hyperviscosity Syndrome in Waldenström Macroglobulinemia [NA]

View source ↗

Summary

This is an ongoing clinical study evaluating hyperviscosity syndrome in patients with Waldenström macroglobulinemia; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Hyperviscosity Syndrome, Waldenstrom Macroglobulinemia | NA | Status: RECRUITING